Stay updated with breaking news from Ensysce Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Free Report) – Analysts at HC Wainwright issued their Q2 2023 earnings estimates for shares of Ensysce Biosciences in a research note issued on Monday, July 3rd. HC Wainwright analyst B. Pachaiyappan forecasts that the company will post earnings of ($1.23) per share for the quarter. HC Wainwright currently has […]
HC Wainwright reiterated their buy rating on shares of Ensysce Biosciences (NASDAQ:ENSC – Free Report) in a research note issued to investors on Monday morning, MarketBeat.com reports. HC Wainwright also issued estimates for Ensysce Biosciences’ Q2 2023 earnings at ($1.23) EPS, Q3 2023 earnings at ($0.91) EPS, Q4 2023 earnings at ($0.70) EPS, FY2023 earnings […]
<iframe src=https://www.youtube.com/embed/E5Z-MqXkTOI></iframe>Ensysce Bioscience CEO Dr Lynn Kirkpatrick joined Steve Darling from Proactive to share more details about the company that... | June 15, 2023
Ensysce Bioscience CEO Dr. Lynn Kirkpatrick joined Steve Darling from Proactive to share more details about the company that has proprietary technology...
Ensysce Biosciences, Inc. (OTCMKTS:ENSC – Get Rating) – Equities research analysts at Zacks Investment Research dropped their Q3 2022 earnings per share (EPS) estimates for Ensysce Biosciences in a research note issued on Tuesday, May 17th. Zacks Investment Research analyst B. Sorensen now expects that the company will earn ($0.22) per share for the quarter, […]